Innovations in Thoracic Oncology and the Promise of Liquid Biopsies with Dr. Luis Raez
Thoracic oncology continues to pose a great threat to human health as one of the most common forms of cancer. Liquid biopsies present a transformative approach to treating patients affected by these types of diseases by providing a less invasive genetic overview of the tumor, aiding in both diagnost...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-02-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/16/4/799 |
| _version_ | 1797298633831350272 |
|---|---|
| author | Viviana Cortiana Alexandra Van de Kieft Harshal Chorya Jade Gambill Chandler H. Park Yan Leyfman |
| author_facet | Viviana Cortiana Alexandra Van de Kieft Harshal Chorya Jade Gambill Chandler H. Park Yan Leyfman |
| author_sort | Viviana Cortiana |
| collection | DOAJ |
| description | Thoracic oncology continues to pose a great threat to human health as one of the most common forms of cancer. Liquid biopsies present a transformative approach to treating patients affected by these types of diseases by providing a less invasive genetic overview of the tumor, aiding in both diagnostic and treatment measures. The primary objective of this article is to examine the prospects of liquid biopsies in managing thoracic malignancies and to present barriers to their usage as demonstrated by Dr. Luis Raez. In examining why molecular diagnostics continue to be employed together with more traditional methods, this article presents the next steps in the clinical application of blood-based cancer screening. Future cancer diagnosis and treatment aim to prioritize circulating biomarker analyses based on their potential for the detection and monitoring of thoracic cancers. Liquid biopsies are favored thanks to their reduced invasiveness with respect to traditional treatments. The further study of clinical biomarkers and technological advancements are thus pivotal to enhance the clinical applicability of this method. In conclusion, this blood-based analysis offers a promising route by which the diagnosis, treatments, and outcomes of thoracic cancer can be improved. |
| first_indexed | 2024-03-07T22:38:52Z |
| format | Article |
| id | doaj.art-9fa45d4d249743eab8b226c8ac3d1095 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-07T22:38:52Z |
| publishDate | 2024-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-9fa45d4d249743eab8b226c8ac3d10952024-02-23T15:11:16ZengMDPI AGCancers2072-66942024-02-0116479910.3390/cancers16040799Innovations in Thoracic Oncology and the Promise of Liquid Biopsies with Dr. Luis RaezViviana Cortiana0Alexandra Van de Kieft1Harshal Chorya2Jade Gambill3Chandler H. Park4Yan Leyfman5Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, ItalyCornell University, Ithaca, NY 14853, USAMedical College Baroda, Vadodara 390018, IndiaParker University, Dallas, TX 75229, USANorton Cancer Institute, Louisville, KY 40202, USAIcahn School of Medicine at Mount Sinai, New York, NY 10029, USAThoracic oncology continues to pose a great threat to human health as one of the most common forms of cancer. Liquid biopsies present a transformative approach to treating patients affected by these types of diseases by providing a less invasive genetic overview of the tumor, aiding in both diagnostic and treatment measures. The primary objective of this article is to examine the prospects of liquid biopsies in managing thoracic malignancies and to present barriers to their usage as demonstrated by Dr. Luis Raez. In examining why molecular diagnostics continue to be employed together with more traditional methods, this article presents the next steps in the clinical application of blood-based cancer screening. Future cancer diagnosis and treatment aim to prioritize circulating biomarker analyses based on their potential for the detection and monitoring of thoracic cancers. Liquid biopsies are favored thanks to their reduced invasiveness with respect to traditional treatments. The further study of clinical biomarkers and technological advancements are thus pivotal to enhance the clinical applicability of this method. In conclusion, this blood-based analysis offers a promising route by which the diagnosis, treatments, and outcomes of thoracic cancer can be improved.https://www.mdpi.com/2072-6694/16/4/799thoracic oncologylung cancerliquid biopsiesbiomarkers |
| spellingShingle | Viviana Cortiana Alexandra Van de Kieft Harshal Chorya Jade Gambill Chandler H. Park Yan Leyfman Innovations in Thoracic Oncology and the Promise of Liquid Biopsies with Dr. Luis Raez Cancers thoracic oncology lung cancer liquid biopsies biomarkers |
| title | Innovations in Thoracic Oncology and the Promise of Liquid Biopsies with Dr. Luis Raez |
| title_full | Innovations in Thoracic Oncology and the Promise of Liquid Biopsies with Dr. Luis Raez |
| title_fullStr | Innovations in Thoracic Oncology and the Promise of Liquid Biopsies with Dr. Luis Raez |
| title_full_unstemmed | Innovations in Thoracic Oncology and the Promise of Liquid Biopsies with Dr. Luis Raez |
| title_short | Innovations in Thoracic Oncology and the Promise of Liquid Biopsies with Dr. Luis Raez |
| title_sort | innovations in thoracic oncology and the promise of liquid biopsies with dr luis raez |
| topic | thoracic oncology lung cancer liquid biopsies biomarkers |
| url | https://www.mdpi.com/2072-6694/16/4/799 |
| work_keys_str_mv | AT vivianacortiana innovationsinthoraciconcologyandthepromiseofliquidbiopsieswithdrluisraez AT alexandravandekieft innovationsinthoraciconcologyandthepromiseofliquidbiopsieswithdrluisraez AT harshalchorya innovationsinthoraciconcologyandthepromiseofliquidbiopsieswithdrluisraez AT jadegambill innovationsinthoraciconcologyandthepromiseofliquidbiopsieswithdrluisraez AT chandlerhpark innovationsinthoraciconcologyandthepromiseofliquidbiopsieswithdrluisraez AT yanleyfman innovationsinthoraciconcologyandthepromiseofliquidbiopsieswithdrluisraez |